“We are encouraged by the bipartisan support for this legislation—it encompasses many critical first steps toward fighting the nationwide opioid use epidemic,” said APA CEO and Medical Director Saul Levin, M.D., M.P.A. “But we cannot stop here. These programs must be fully funded to be effective. APA looks forward to continuing to work with Congress to curb this epidemic.”
When funded, CARA will provide grants to expand access to opioid overdose reversal drugs (such as naloxone) and support addiction treatment services, including those using buprenorphine and other medication-assisted treatments.
The legislation also will offer grants to community organizations to develop and enhance recovery services and link those services to other recovery support systems. Grants will be available to states for opioid abuse education, treatment, and recovery efforts, prescription drug monitoring programs, and efforts to prevent overdose deaths.
For more in Psychiatric News about Congressional action on opioid abuse, see “House Members Consider Best Options for Treatment, Prevention of Opioid Abuse.”